Biocon Biologics Joins Hands with Malaysia’s Cancer Society—Boosts Patient Support & Access

Biocon Biologics Malaysia, a subsidiary of Biocon Ltd., has partnered with the National Cancer Society Malaysia (NCSM) to support cancer patients affected by recent floods. As part of its CSR initiative, Biocon employees contributed essential supplies—including food, thermal blankets, and hygiene kits—to over 45 cancer patients and survivors displaced by the disaster.

 

This collaboration underscores Biocon’s commitment to community health and resilience, especially for vulnerable groups battling both illness and environmental hardship. The initiative complements Biocon Biologics’ broader mission in Malaysia, where it operates Asia’s largest integrated insulin manufacturing facility and continues to expand access to affordable biosimilars for chronic diseases like cancer and diabetes.

 

Key Highlights:

This initiative reflects Biocon’s dual focus on cutting-edge healthcare and compassionate outreach in Southeast Asia.

 

Source: CSR Malaysia – Biocon Malaysia Flood Relief for Cancer Patients